Behdad Behnam

748 total citations
29 papers, 554 citations indexed

About

Behdad Behnam is a scholar working on Neurology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Behdad Behnam has authored 29 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Pathology and Forensic Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Behdad Behnam's work include Multiple Sclerosis Research Studies (4 papers), COVID-19 Clinical Research Studies (4 papers) and Long-Term Effects of COVID-19 (4 papers). Behdad Behnam is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), COVID-19 Clinical Research Studies (4 papers) and Long-Term Effects of COVID-19 (4 papers). Behdad Behnam collaborates with scholars based in Iran and United Kingdom. Behdad Behnam's co-authors include Shahin Akhondzadeh, Mehran Arab Ahmadi, Heresh Amini, Maryam Tabatabaee, S. A. Abbasi, Alireza Abrishami, Peyman Mohammadi Torbati, Farzad Ashrafi, Nooshin Dalili and Morteza Sanei Taheri and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Urology and Schizophrenia Research.

In The Last Decade

Behdad Behnam

27 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Behdad Behnam Iran 10 179 131 125 91 88 29 554
Thiago Macedo e Cordeiro Brazil 10 119 0.7× 107 0.8× 70 0.6× 22 0.2× 64 0.7× 17 466
Lalit Gupta India 15 68 0.4× 49 0.4× 53 0.4× 56 0.6× 23 0.3× 110 734
Xiaoqian Luan China 14 71 0.4× 19 0.1× 39 0.3× 35 0.4× 59 0.7× 46 581
Vishwadeep Ahluwalia United States 12 54 0.3× 63 0.5× 38 0.3× 26 0.3× 27 0.3× 23 771
Ruchika Garg India 13 49 0.3× 30 0.2× 27 0.2× 28 0.3× 41 0.5× 93 491
Antonio Martocchia Italy 13 38 0.2× 32 0.2× 27 0.2× 92 1.0× 37 0.4× 44 480
Lana Fani Netherlands 15 50 0.3× 10 0.1× 79 0.6× 41 0.5× 45 0.5× 22 693
Ai Kimura Japan 17 159 0.9× 21 0.2× 169 1.4× 10 0.1× 37 0.4× 38 912
Yueli Zhu China 12 36 0.2× 86 0.7× 30 0.2× 21 0.2× 75 0.9× 23 466
Janko Samardžić Serbia 13 25 0.1× 26 0.2× 39 0.3× 46 0.5× 22 0.3× 63 522

Countries citing papers authored by Behdad Behnam

Since Specialization
Citations

This map shows the geographic impact of Behdad Behnam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behdad Behnam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behdad Behnam more than expected).

Fields of papers citing papers by Behdad Behnam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behdad Behnam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behdad Behnam. The network helps show where Behdad Behnam may publish in the future.

Co-authorship network of co-authors of Behdad Behnam

This figure shows the co-authorship network connecting the top 25 collaborators of Behdad Behnam. A scholar is included among the top collaborators of Behdad Behnam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behdad Behnam. Behdad Behnam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Behnam, Behdad, et al.. (2023). ChatGPT in Iranian medical licensing examination: evaluating the diagnostic accuracy and decision-making capabilities of an AI-based model. BMJ Health & Care Informatics. 30(1). e100815–e100815. 27 indexed citations
2.
Abrishami, Alireza, Shiva Samavat, Behdad Behnam, et al.. (2020). Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients. European Urology. 78(2). 281–286. 50 indexed citations
3.
Abrishami, Alireza, et al.. (2020). Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study. European Journal of Nutrition. 60(4). 2249–2257. 74 indexed citations
4.
Ashrafi, Farzad, Alireza Zali, Mehri Salari, et al.. (2020). COVID-19-related strokes in adults below 55 years of age: a case series. Neurological Sciences. 41(8). 1985–1989. 31 indexed citations
5.
Mokhtare, Marjan, Mehdi Nikkhah, Behdad Behnam, et al.. (2020). A comparative study of the effect of 10-day esomeprazole containing levofloxacin versus clarithromycin sequential regimens on the treatment of Iranian patients with Helicobacter pylori infection. Indian Journal of Pharmacology. 52(4). 266–266. 3 indexed citations
6.
Zali, Alireza, et al.. (2020). The Deadly Cost of Ignorance: The Risk of Second Wave of COVID-19. Asia Pacific Journal of Public Health. 32(8). 511–512. 3 indexed citations
7.
8.
Behnam, Behdad, et al.. (2019). Autoimmune Haemolytic Anaemia and Multiple Autoimmune Syndrome. SHILAP Revista de lepidopterología. 6(Vol 6 No 5). 1–1. 2 indexed citations
9.
Hassanian‐Moghaddam, Hossein, et al.. (2017). Intracranial hemorrhage in methanol toxicity: Challenging the probable heparin effect during hemodialysis. Journal of Research in Pharmacy Practice. 6(3). 186–186. 7 indexed citations
10.
Harandi, Ali Amini, Mehdi Abbasi, Farzad Ashrafi, et al.. (2017). Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study. Dementia and Geriatric Cognitive Disorders Extra. 7(1). 136–142. 7 indexed citations
11.
Pakdaman, Hossein, Ali Amini Harandi, Mehdi Abbasi, et al.. (2016). Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran. Neurological Sciences. 37(11). 1773–1778. 20 indexed citations
12.
Behnam, Behdad, et al.. (2016). Imerslund-Grasbeck syndrome in a 5-year-old Iranian boy. Indian Journal of Nephrology. 26(6). 455–455. 3 indexed citations
13.
Pakdaman, Hossein, Ali Amini Harandi, Mehdi Abbasi, et al.. (2016). Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran. International Journal of Neuroscience. 127(6). 501–507. 9 indexed citations
14.
Zali, Alireza, Farzad Ashrafi, Sohrab Shahzadi, et al.. (2015). The Spine Vertebral Bodies 3D Modeling and its Biomechanical Advantages. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Ashrafi, Farzad, et al.. (2015). A Child with Moyamoya Disease: A Case Report. SHILAP Revista de lepidopterología.
16.
Ashrafi, Farzad, et al.. (2015). Association Between Cognitive Function and Metabolic Syndrome Using Montreal Cognitive Assessment Test. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Behnam, Behdad, et al.. (2015). Warfarin-induced Eosinophilia in a Child with urkitt Lymphoma: A Case Report.. PubMed Central. 14(3). 887–90. 9 indexed citations
18.
Ahmadi, Mehran Arab, Farzad Ashrafi, & Behdad Behnam. (2015). Comparison of Montreal Cognitive Assessment test and Mini Mental State Examination in detecting cognitive impairment in relapsing-remitting multiple sclerosis patients. SHILAP Revista de lepidopterología. 2(4). 137–141. 7 indexed citations
19.
Bahrami‐Motlagh, Hooman, Hossein Hassanian‐Moghaddam, Behdad Behnam, & Mehran Arab Ahmadi. (2015). Failure of surgical treatment in methamphetamine body-stuffers. Journal of Forensic and Legal Medicine. 32. 70–72. 11 indexed citations
20.
Akhondzadeh, Shahin, et al.. (2007). Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. Schizophrenia Research. 90(1-3). 179–185. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thiago Macedo e Cordeiro Breakdown of academic impact, for papers by Lalit Gupta Breakdown of academic impact, for papers by Xiaoqian Luan Breakdown of academic impact, for papers by Vishwadeep Ahluwalia Breakdown of academic impact, for papers by Ruchika Garg Breakdown of academic impact, for papers by Antonio Martocchia Breakdown of academic impact, for papers by Lana Fani Breakdown of academic impact, for papers by Ai Kimura Breakdown of academic impact, for papers by Yueli Zhu Breakdown of academic impact, for papers by Janko Samardžić
Rankless by CCL
2026